197 related articles for article (PubMed ID: 11731187)
41. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
42. Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being.
Odmark IS; Bäckström T; Jonsson B; Bixo M
Gynecol Endocrinol; 2004 Jun; 18(6):305-17. PubMed ID: 15497493
[TBL] [Abstract][Full Text] [Related]
43. The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms.
Speroff L; Symons J; Kempfert N; Rowan J;
Menopause; 2000; 7(6):383-90. PubMed ID: 11127760
[TBL] [Abstract][Full Text] [Related]
44. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Marslew U; Munk-Nielsen N; Nilas L; Riis BJ; Christiansen C
Maturitas; 1994 Oct; 19(3):225-37. PubMed ID: 7799829
[TBL] [Abstract][Full Text] [Related]
45. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy.
Stadberg E; Mattsson LA; Uvebrant M
Maturitas; 1996 Feb; 23(1):31-9. PubMed ID: 8861084
[TBL] [Abstract][Full Text] [Related]
46. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
[TBL] [Abstract][Full Text] [Related]
47. A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings.
Heikkinen J; Vaheri R; Timonen U
J Br Menopause Soc; 2006 Sep; 12(3):115-25. PubMed ID: 16953985
[TBL] [Abstract][Full Text] [Related]
48. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
[TBL] [Abstract][Full Text] [Related]
49. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
50. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
Brynhildsen J; Hammar M
Menopause; 2002; 9(2):137-44. PubMed ID: 11875333
[TBL] [Abstract][Full Text] [Related]
51. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
Sturdee DW; Archer DF; Rakov V; Lang E;
Climacteric; 2008 Feb; 11(1):63-73. PubMed ID: 18202966
[TBL] [Abstract][Full Text] [Related]
52. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens.
Heikkinen J; Vaheri R; Kainulainen P; Timonen U
Osteoporos Int; 2000; 11(11):929-37. PubMed ID: 11193245
[TBL] [Abstract][Full Text] [Related]
53. Continuous combined hormone replacement therapy compared with tibolone.
Al-Azzawi F; Wahab M; Habiba M; Akkad A; Mason T
Obstet Gynecol; 1999 Feb; 93(2):258-64. PubMed ID: 9932566
[TBL] [Abstract][Full Text] [Related]
54. Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
Gambacciani M; Spielmann D; Genazzani AR
Gynecol Endocrinol; 2005 Aug; 21(2):65-73. PubMed ID: 16294457
[TBL] [Abstract][Full Text] [Related]
55. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
56. Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives.
Garceau RJ; Wajszczuk CJ; Kaunitz AM;
Contraception; 2000 Dec; 62(6):289-95. PubMed ID: 11239615
[TBL] [Abstract][Full Text] [Related]
57. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
58. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Jensen J; Riis BJ; Strøm V; Christiansen C
Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
[TBL] [Abstract][Full Text] [Related]
59. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Lübbert H; Nauert C
Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
[TBL] [Abstract][Full Text] [Related]
60. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
Limpaphayom KK; Bunyavejchevin S
J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
